BackIdeaya Biosciences Overview
Ideaya Biosciences Inc

Ideaya Biosciences Target Price

Where could IDYA trade next? Consensus target price: $57.

Get informed when a big investor buys or sells

+ Follow

Share Price

$37.59

Average Target Price

$57.0051.6% upside

4 analysts in the last 4 months

High: $63 | Low: $48

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09Guggenheim$5751.6% upsideOpen
2026-08-05Wedbush$6059.6% upsideOpen
2026-07-07Truist FinancialGregory Renza$6367.6% upsideOpen
2026-07-07RBC Capital$4827.7% upsideOpen
2026-04-14Wedbush$5854.3% upsideOpen
2026-04-14RBC Capital$5341% upsideOpen
2026-04-13Truist Financial$6572.9% upsideOpen
2026-02-18Wedbush$5238.3% upsideOpen
2026-01-21RBC Capital$4519.7% upsideOpen
2026-01-06Truist FinancialGregory Renza$6059.6% upsideOpen
2025-11-24Truist Financial$5957% upsideOpen
2025-10-21New Street$3020.2% downsideOpen
2025-10-21RBC Capital$419.1% upsideOpen
2025-09-17Guggenheim$5033% upsideOpen
2025-09-09RBC CapitalGregory Renza$381.1% upsideOpen
2025-09-08OppenheimerMatthew Biegler$364.2% downsideOpen
2025-09-04JMP Securitieslvan Tuerkcan$419.1% upsideOpen
2025-09-04Barclays$406.4% upsideOpen
2024-11-05Leerink PartnersAndrew Berens$2728.2% downsideOpen
2024-10-24UBSDavid Dai$5033% upsideOpen
2024-09-25Mizuho SecuritiesGraig Suvannavejh$5546.3% upsideOpen
2024-09-23Goldman SachsCorinne Jenkins$4827.7% upsideOpen
2024-09-23Stifel NicolausBen Burnett$6675.6% upsideOpen
2024-09-23BTIGJustin Zelin$6264.9% upsideOpen
2024-09-10Stifel NicolausBen Burnett$6880.9% upsideOpen
2024-08-27CitigroupYigal Nochomovitz$5854.3% upsideOpen
2024-08-07OppenheimerMatthew Biegler$5341% upsideOpen
2024-07-10RBC CapitalGregory Renza$6162.3% upsideOpen
2024-07-08Mizuho SecuritiesGraig Suvannavejh$5033% upsideOpen
2024-06-03Stifel NicolausBen Burnett$6367.6% upsideOpen
2022-12-28Capital One Financial$2922.9% downsideOpen
2022-09-13Guggenheim$3214.9% downsideOpen
2022-08-18Oppenheimer$2046.8% downsideOpen
2022-08-16Robert W. Baird$1852.1% downsideOpen

Ideaya Biosciences (IDYA) FAQ

As of the most recent data, IDYA shows a target price of $57. Scroll down for historical charts and peer comparison views.

If Ideaya Biosciences moved to the average analyst target of $57, shares would be roughly 51.6% higher than $37.59. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Ideaya Biosciences's earnings trajectory.

Besides this target price page, Stockcircle has Ideaya Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $57) with ownership activity and broader fundamentals.

Ideaya Biosciences's target price is $57; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.